Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2022-02-03
Original market date: See footnote 1
2000-10-20
Product name:
TARO-ETODOLAC
DIN:
02242915 Electronic product monograph is not available
Company:
TARO PHARMACEUTICALS INC
130 East Drive
Brampton
Ontario
Canada
L6T 1C1
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
28:08.04.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
M01AB08 ETODOLAC
Active ingredient group (AIG) number:See footnote5
0116345002
Active ingredient(s) | Strength |
---|---|
ETODOLAC | 300 MG |